Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission

Erica D. Warlick, Kristjan Paulson, Ruta Brazauskas, Xiaobo Zhong, Alan M. Miller, Bruce M. Camitta, Biju George, Bipin N. Savani, Celalettin Ustun, David I. Marks, Edmund K. Waller, Frederic Baron, Cesar O. Freytes, Gerard Socie, Gorgun Akpek, Harry C. Schouten, Hillard M. Lazarus, Edwin M. Horwitz, John Koreth, Jean-Yves CahnMartin Bornhauser, Matthew Seftel, Mitchell S. Cairo, Mary. J. Laughlin, Mitchell Sabloff, Olle Ringden, Robert Peter Gale, Rammurti T. Kamble, Ravi Vij, Usama Gergis, Vikram Mathews, Wael Saber, Yi-Bin Chen, Jane L. Liesveld, Corey S. Cutler, Armin Ghobadi, Geoffrey L. Uy, Mary Eapen, Daniel J. Weisdorf, Mark R. Litzow

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)202-208
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number2
DOIs
Publication statusPublished - Feb 2014

Keywords

  • AML
  • RIC
  • Cytarabine consolidation

Cite this

Warlick, E. D., Paulson, K., Brazauskas, R., Zhong, X., Miller, A. M., Camitta, B. M., George, B., Savani, B. N., Ustun, C., Marks, D. I., Waller, E. K., Baron, F., Freytes, C. O., Socie, G., Akpek, G., Schouten, H. C., Lazarus, H. M., Horwitz, E. M., Koreth, J., ... Litzow, M. R. (2014). Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission. Biology of Blood and Marrow Transplantation, 20(2), 202-208. https://doi.org/10.1016/j.bbmt.2013.10.023